Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 1/20 | 0.53 |
| ▸ | FABP3 | P05413 | 1/20 | 0.47 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.47 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.42 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.42 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4222844 | 0.90 | FABP3 (0.50) | SELPFABP3NR5A2NR5A1LPAR3 | |
| SCHEMBL2360799 | 0.89 | S1PR1 (0.53) | SELPFABP3NR5A2NR5A1LPAR3 | |
| SCHEMBL6704299 | 0.84 | S1PR1 (0.48) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL6510371 | 0.84 | S1PR1 (0.48) | SELPFABP3LPAR3LPAR1ENPP2 | |
| SCHEMBL12272715 | 0.81 | S1PR1 (0.56) | LPAR3LPAR1ENPP2S1PR1S1PR4 | |
| SCHEMBL17240248 | 0.81 | S1PR1 (0.56) | LPAR3LPAR1ENPP2S1PR1S1PR4 | |
| SCHEMBL15500035 | 0.81 | S1PR1 (0.56) | LPAR3LPAR1ENPP2S1PR1S1PR4 | |
| SCHEMBL4407962 | 0.81 | SMN1; SMN2 (0.56) | SELPFABP3NR5A2NR5A1S1PR1 | |
| SCHEMBL974551 | 0.81 | SMN1; SMN2 (0.56) | SELPFABP3NR5A2NR5A1S1PR1 | |
| SCHEMBL3424607 | 0.80 | PRKCA (0.55) | SELPS1PR1S1PR4S1PR3S1PR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120100077-A1 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100077-A1 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | ANXA2, DNM2, ANXA6 | SELP 916/4885FABP3 94/4885NR5A2 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.